Connecting the PWS Dots | Category

Category /

Research Database: Prader-Willi Syndrome (PWS)

Research Database
(Eiholzer 2008) Developmental profiles in young children with PWS - Effects of GH and CoQ10
(Camfferman 2008) PWS and excessive daytime sleepiness
(Jiang 2008) Genomic analysis of 15q11-q13 PWS region and characterization of GOLGA8E and WHCD1L1 transcripts
(Scheimann 2008) Critical analysis of bariatric procedures in PWS
(Giurgiutiu 2008) Persistent growth failure in PWS associated with SCAD deficiency
(Bachere 2008) Early diagnosis and multidisciplinary care reduce duration of hospitalization time and tube feeding and prevent early obesity in PWS infants
(Stafler 2007) Prader Willi Syndrome: Who can have growth hormone?
(Yee 2007) Assessment of sleep and breathing in adults with PWS
(Festen 2007) Mental and motor development before and during GH treatment in infants and toddlers with PWS
(Unanue 2007) Adrenarche in PWS is not related to insulin sensitivity and serum adiponectin
(Danielsson 2007) Impact of sibutramine in children with hypothalamic obesity
(Stegmann 2007) Screening of patients with unexplained mental retardation using subtelomeric MLPA
(Lin 2007) Polysomnographic characteristics in PWS
(Herguner 2007) Psychosis associated with fluoxetine in PWS
(Festen 2007) Psychomotor development in infants with PWS and sleep-related breathing disorders
(Carvalho 2007) Therapeutical approach to obesity in PWS
(Van Borsel 2007) Fluency disorders in genetic syndromes
(Eiholzer 2007) Clinical effects of treatment for hypogonadism in male adolescents with PWS
(Nagarajan 2006) Reduced MeCP2 expression is frequent in autism frontal cortex
(Priano 2006) Sleep cycling alternating pattern is associated with hypersomnia and GH secretory pattern in PWS
(Smit 2006) Cataplexy leading to the diagnosis of Niemann-Pick disease type C
(Kishore 2006) snoRNA HBII-52 regulates alternative splicing of serotonin receptor 2C
(Verhoeven 2006) PWS: Atypical psychoses and motor dysfunctions
(Kishore 2006) Regulation of alternative splicing by snoRNAs
(O'Donoghue 2005) Sleep-disordered breathing in PWS - association with neurobehavioral abnormalities
(Stefan 2005) Hormonal and metabolic defects in PWS mouse model with neonatal failure to thrive
(Nevsimalova 2005) Hypocretin deficiency in Prader-Willi syndrome
(Dhossche 2005) Is there a connection between autism, PWS, catatonia and GABA?
(Noczyńska 2004) Hyperprolactinemia in children during the peripubertal period
(Eiholzer 2004) Growth hormone and body composition in children younger than 2 years with PWS
(Kennedy-Kreiger 2003) Winning the weight loss battle - teen with PWS
(Eiholzer 2003) Improving body composition and physical activity in PWS
(Tobias 2002) Cataplexy in Prader-Willi syndrome
(Whitman 2002) Behavioral impact of growth hormone treatment for PWS
(L'allemand 2002) Increased adrenal androgen levels in PWS associated with insulin, IGF-I and leptin but not obesity
(Eiholzer 2002) Fatal outcome of sleep apnoea in PWS during initial phase of GH treatment
(Ebert 1997) Elevated plasma GABA in PWS and Angelman syndrome
{Hashizume 1991) Prader-Willi syndrome associated with hepatoblastoma
(Donhauser 1991) Pseudo-Kaposi sarcoma in Prader-Labhart-Willi syndrome
(Chasalow 1987) Steroid metabolic disturbances in Prader-Willi syndrome
(Nelson 1970) Ketogenic diet and Prader-Willi syndrome
(Johnsen 1967) Fasting hyperlipogenesis: An inborn error of energy metabolism in PWS